These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

610 related items for PubMed ID: 17395035

  • 1. Pharmacotherapies for diabetes management: an update for the practicing clinician.
    Meneghini L, Hirsch IB.
    Semin Thorac Cardiovasc Surg; 2006; 18(4):379-89. PubMed ID: 17395035
    [Abstract] [Full Text] [Related]

  • 2. Physiologic insulin replacement in type 2 diabetes: optimizing postprandial glucose control.
    Robertson C.
    Diabetes Educ; 2006; 32(3):423-32. PubMed ID: 16772658
    [Abstract] [Full Text] [Related]

  • 3. The role of glimepiride in the effective management of Type 2 diabetes.
    Davis SN.
    J Diabetes Complications; 2004; 18(6):367-76. PubMed ID: 15531188
    [Abstract] [Full Text] [Related]

  • 4. Insulin strategies for managing inpatient and outpatient hyperglycemia and diabetes.
    Moghissi ES.
    Mt Sinai J Med; 2008 Dec 01; 75(6):558-66. PubMed ID: 19021195
    [Abstract] [Full Text] [Related]

  • 5. Management of diabetes in the hospital.
    Fonseca V.
    Rev Cardiovasc Med; 2006 Dec 01; 7 Suppl 2():S10-7. PubMed ID: 17224872
    [Abstract] [Full Text] [Related]

  • 6. Treatment of type 2 diabetes with combined therapy: what are the pros and cons?
    Massi-Benedetti M, Orsini-Federici M.
    Diabetes Care; 2008 Feb 01; 31 Suppl 2():S131-5. PubMed ID: 18227473
    [Abstract] [Full Text] [Related]

  • 7. Insulin therapy for maximal glycemic control in type 2 diabetes mellitus.
    Spellman CW.
    J Am Osteopath Assoc; 2007 Jul 01; 107(7):260-9. PubMed ID: 17682113
    [Abstract] [Full Text] [Related]

  • 8. Optimizing insulin therapy in patients with type 1 and type 2 diabetes mellitus: optimal dosing and timing in the outpatient setting.
    Hahr AJ, Molitch ME.
    Am J Ther; 2008 Jul 01; 15(6):543-50. PubMed ID: 19127139
    [Abstract] [Full Text] [Related]

  • 9. Dosing of insulin glargine in the treatment of type 2 diabetes.
    Barnett A.
    Clin Ther; 2007 Jun 01; 29(6):987-99. PubMed ID: 17692716
    [Abstract] [Full Text] [Related]

  • 10. When oral agents fail: optimizing insulin therapy in the older adult.
    Meece J.
    Consult Pharm; 2009 Jun 01; 24 Suppl B():11-7. PubMed ID: 19555131
    [Abstract] [Full Text] [Related]

  • 11. Minimizing the risk of hypoglycemia in older adults: a focus on long-term care.
    Garza H.
    Consult Pharm; 2009 Jun 01; 24 Suppl B():18-24. PubMed ID: 19555132
    [Abstract] [Full Text] [Related]

  • 12. The rationale for paired pre- and postprandial self-monitoring of blood glucose: the role of glycemic variability in micro- and macrovascular risk.
    Gerich JE, Odawara M, Terauchi Y.
    Curr Med Res Opin; 2007 Aug 01; 23(8):1791-8. PubMed ID: 17610805
    [Abstract] [Full Text] [Related]

  • 13. Long-term benefits of insulin therapy and glycemic control in overweight and obese adults with type 2 diabetes.
    Caballero AE.
    J Diabetes Complications; 2009 Aug 01; 23(2):143-52. PubMed ID: 18413192
    [Abstract] [Full Text] [Related]

  • 14. Weight gain during insulin therapy in patients with type 2 diabetes mellitus.
    Heller S.
    Diabetes Res Clin Pract; 2004 Sep 01; 65 Suppl 1():S23-7. PubMed ID: 15315867
    [Abstract] [Full Text] [Related]

  • 15. Antidiabetic therapy before and 1 year after discharge for patients manifesting in-hospital hyperglycemia.
    Waddell M, Flanders SJ, Golas A, Zhang Q, Juneja R.
    Postgrad Med; 2009 May 01; 121(3):61-6. PubMed ID: 19491541
    [Abstract] [Full Text] [Related]

  • 16. Improved glycaemic control with BIAsp 30 in insulin-naïve type 2 diabetes patients inadequately controlled on oral antidiabetics: subgroup analysis from the IMPROVE study.
    Wenying Y, Benroubi M, Borzi V, Gumprecht J, Kawamori R, Shaban J, Shah S, Shestakova M, Ligthelm R, Valensi P, IMPROVE Study Group Expert Panel.
    Curr Med Res Opin; 2009 Nov 01; 25(11):2643-54. PubMed ID: 19751116
    [Abstract] [Full Text] [Related]

  • 17. Improving patient acceptance and adherence in diabetes management: a focus on insulin therapy.
    Rakel RE.
    Adv Ther; 2009 Sep 01; 26(9):838-46. PubMed ID: 19768641
    [Abstract] [Full Text] [Related]

  • 18. New concepts in diabetes: how multihormonal regulation can improve glycemic control.
    Blonde L, Baker DE, Davis SN, Ratner RE.
    J Manag Care Pharm; 2004 Dec 01; 10(6 Suppl B):S3-8; quiz S9, S11-2. PubMed ID: 23570175
    [Abstract] [Full Text] [Related]

  • 19. Transitioning pharmacologic therapy from oral agents to insulin for type 2 diabetes.
    Tanenberg RJ.
    Curr Med Res Opin; 2004 Apr 01; 20(4):541-53. PubMed ID: 15119992
    [Abstract] [Full Text] [Related]

  • 20. Diabetes: the latest trends in glycemic control.
    Giurini JM, Cook EA, Cook JJ.
    Clin Podiatr Med Surg; 2007 Apr 01; 24(2):159-89. PubMed ID: 17430766
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 31.